Page 2 - Marinus Verwijs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CTO Marinus Verwijs sold 970 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $10.46, for a total value of $10,146.20. The transaction was disclosed in a filing with the SEC, which is accessible through […] ....

United States , Marinus Verwijs , Jpmorgan Chase Co , York Mellon Corp , American International Group Inc , Vanguard Group Inc , Blackrock Inc , Aerovate Therapeutics Inc , Aerovate Therapeutics , Get Free Report , New York Mellon Corp , American International Group , International Group , Aerovate Therapeutics Daily , Nasdaq Avte , Insider Trading , Nsider Trades ,